# AbX Biologics, Inc. — Form D/A

AbX Biologics, Inc. of CANTON, MA, a company, filed a Form D amendment with the SEC on 2019-10-11. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Other.

## Offering

- Filed: 2019-10-11
- Form: D/A
- Accession: 0001783034-19-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 5
- Date of first sale: 2019-07-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-344776

## Issuer

- Name: AbX Biologics, Inc.
- CIK: 0001783034
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 480 NEPONSET STREET, SUITE 10B, CANTON, MA, 02021
- Phone: 603-767-9155

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Garren Hilow | Director | Canton, MA |
| Garren Hilow | Executive Officer | Canton, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-07-22](https://search.stillhousedata.com/formd/0001783034-19-000001) | D | $750K | $350K |

## More

- [CIK 1783034 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1783034&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001783034-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.